Nuvo Research continues significant uptrend; increases 1.1% March 01, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
Nuvo Research Inc. (TSX:NRI), Canada's 4th largest Drug manufacturers company by market cap, has increased 7.0c (1.1%) from its last trading session of February 28 to close at CAD6.20. Compared with the S&P/TSX 60 Index which rose 11.1 points (1.2%) in the day, the relative price change was -0.1%. The volume was 0.1 times the average daily trading volume of 24,784 shares.
NUVO RESEARCH BULLISH SIGNALS